P2Y12 adenosine receptor inhibitors preloading among patients with non‐ST‐elevation acute coronary syndromes; insights from a nationwide multicenter registry
Sign Up to like & getrecommendations! Published in 2024 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.31143
Abstract: The safety and efficacy of treatment with P2Y12 adenosine‐diphosphate receptor inhibitors (P2Y12‐RI) before coronary angiography among patients with non‐ST‐segment elevation acute coronary syndromes (NSTEACS) are questionable. read more here.
Keywords: patients non; among patients; receptor inhibitors; acute coronary ... See more keywords